An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we move away from sending confirmatory results via fax and implement sending them directly to your email.
Check out the Communication page for the complete details by clicking the link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...